Results 191 to 200 of about 10,242 (284)

Real-World Switch Rates, Treatment Patterns, and Healthcare Costs Among Patients With Spasticity Treated With Botulinum Toxins. [PDF]

Adv Ther
Dominguez A, Shah D, Cheng N, Manthena S.   +3 more
europepmc   +1 more source

Adverse Drug Reaction Study of Botulinum Toxin‐A in the Real World

Journal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Background Despite the increasing use of botulinum toxin type A (BoNT‐A) in aesthetic and therapeutic applications, its real‐world adverse drug reaction (ADR) profile remains incompletely characterized. Current evidence relies largely on small‐scale clinical observations rather than large, systematic analyses.
Jiaxu Gu, Yue Sun, Kexin Chen, Jieyi Wang, Bingcheng Lu, Hongqiang Xie, Xiaoming Liu, Cong Huang, Xingling Jian, Bo Yu   +9 more
wiley   +1 more source

LetibotulinumtoxinA for Rosacea: A Pilot Study. [PDF]

Toxins (Basel)
Bańka-Wrona A, Wrona W, Barańska-Rybak W.   +2 more
europepmc   +1 more source

Practical aspects of using botulinum toxin type B

Elan\u27s botulinum toxin type B (NeuroBloc((R))/MYOBLOC (TM)) has several potential advantages over the currently available type A toxins. These include a solution to the problems of treating patients with poor responsiveness to the type A toxins ...
Barnes MP
core  

Examining the Influence of Glycemic Management During Sleep on Sleep‐Related Bruxism: A Pilot Study

Journal of Oral Rehabilitation, Volume 53, Issue 6, Page 1105-1117, June 2026.
Stabilisation of blood glucose levels during sleep may improve sleep‐related bruxism (SRB), particularly by suppressing sympathetic nervous system activity. Furthermore, it is expected that these findings will lead to the establishment of new treatment methods for SRB in sleep dentistry.
Tatsuya Taniwaki, Kazuo Okura, Yoshitaka Suzuki, Toyoko Tajima, Akitomo Watanabe, Yoshizo Matsuka   +5 more
wiley   +1 more source

Cholera Toxin-Mediated Targeting of Botulinum Neurotoxin Activity to Pain-Associated Sensory Neurons. [PDF]

Toxins (Basel)
Corrie E, Bresnahan R, Doran C, Leese C, Balmforth MR, Andreou A, Zhantleuova A, Seward EP, Webb ME, Turnbull WB, Davletov B.   +10 more
europepmc   +1 more source

Phenol Neurolysis in Pain and Palliative Medicine

Pain Practice, Volume 26, Issue 5, June 2026.
ABSTRACT Background Pain is a common symptom in palliative care and affects patients' quality of life considerably. Standard analgesics are sometimes insufficient and are associated with substantial side effects. Neurolysis, the targeted destruction of nerves using thermal or chemical agents, offers an additional option for managing localized pain in ...
Jeroen H. A. Creemers, Rachel J. H. Smits, Alopi M. Patel, Robert T. M. van Dongen, Cornelis K. Kramers, Jacqueline M. Bos, Selina E. I. van der Wal   +6 more
wiley   +1 more source

Early Intervention of Hemiplegic Shoulder Pain in the Context of Post-Stroke Shoulder Spasticity: A Canadian Cross-Sectional Survey. [PDF]

Toxins (Basel)
Kassam F, MacRae F, Lechner L, Dow H, Boissonnault È, Huang F, Winston P.   +6 more
europepmc   +1 more source

Effect of the Mutual Interaction of GPNMB and LPAR1 on Cellular Motility and Tumorigenicity in Mammary Epithelial Cells

Pathology International, Volume 76, Issue 6, June 2026.
GPNMB and LPAR1 form a positive feedback loop enhancing LPA signaling. LPA–LPAR1 activates RhoA–ROCK, driving actin reorganization and cell motility. GPNMB–LPAR1 signaling promotes tumorigenic potential. ABSTRACT Glycoprotein non‐metastatic melanoma protein B (GPNMB) is a poor prognostic factor, which is highly expressed in many types of malignant ...
Minori Kimura, Yukari Okita, Erina Iwabuchi, Xinzhu Hong, Yumu Ichikawa, Manar A. Elhinnawi, Hironobu Sasano, Mitsuyasu Kato   +7 more
wiley   +1 more source

Botulinum Toxin (Dysport) to Prevent Radiation-Induced Dysfunction of Salivary Glands in Head and Neck Cancer. [PDF]

Cancer Rep (Hoboken)
Farhan F, Eyvaz-Zadeh I, Forghani S, Shahsavand A, Samiee R, Mansouri S, Abbasi M, Kazemian A, Aghili M, Jafari M, Karimi E, Esmati E, Jafari F.   +12 more
europepmc   +1 more source